Fresenius: annual earnings down 13%

(CercleFinance.com) - Fresenius reports a 13% drop in 2023 net profit to E1.
5bn, but a 3% rise in operating profit (EBIT) to E2.26bn (+2% at constant exchange rates) on revenues that are up 4% to E22.3bn (+6% organic).

The German healthcare services group thus confirms that it has achieved the guidance it revised upwards three months ago for the past financial year, having in particular achieved a strong Q4 and exceeded its annual cost savings target by around 40%.

Fresenius anticipates EBIT growth of between 4% and 8% for 2024, as well as organic sales growth of between 3% and 6%. It is also raising its EBIT cost savings target to around E400m by 2025.


Copyright (c) 2024 CercleFinance.com. All rights reserved.